594 related articles for article (PubMed ID: 29546732)
1. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
2. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation for sickle cell disease.
Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
[TBL] [Abstract][Full Text] [Related]
6. Zinc supplements for treating thalassaemia and sickle cell disease.
Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
11. Preoperative blood transfusions for sickle cell disease.
Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant supplementation for sickle cell disease.
Bolarinwa AB; Oduwole O; Okebe J; Ogbenna AA; Otokiti OE; Olatinwo AT
Cochrane Database Syst Rev; 2024 May; 5(5):CD013590. PubMed ID: 38775255
[TBL] [Abstract][Full Text] [Related]
13. Intermittent oral iron supplementation during pregnancy.
Peña-Rosas JP; De-Regil LM; Gomez Malave H; Flores-Urrutia MC; Dowswell T
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009997. PubMed ID: 26482110
[TBL] [Abstract][Full Text] [Related]
14. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
15. Effects and safety of periconceptional oral folate supplementation for preventing birth defects.
De-Regil LM; Peña-Rosas JP; Fernández-Gaxiola AC; Rayco-Solon P
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007950. PubMed ID: 26662928
[TBL] [Abstract][Full Text] [Related]
16. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
17. Interventions for treating neuropathic pain in people with sickle cell disease.
Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
[TBL] [Abstract][Full Text] [Related]
18. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Rankine-Mullings AE; Owusu-Ofori S
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD003427. PubMed ID: 33724440
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
Aboursheid T; Albaroudi O; Alahdab F
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
